XML 69 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
Marketable Securities
12 Months Ended
Dec. 31, 2012
Marketable Securities  
Marketable Securities

5. Marketable Securities

        Available-for-sale marketable securities and cash and cash equivalents consist of the following (in thousands):

 
  December 31, 2012  
 
  Amortized Cost Value   Gross Unrealized Gains   Gross Unrealized Losses   Fair Value  

Cash and cash equivalents:

                         

Cash

  $ 1,134   $   $   $ 1,134  

Money market

    16,020             16,020  

Domestic corporate commercial paper

    1,499             1,499  
                   

Total

  $ 18,653   $   $   $ 18,653  
                   

Marketable securities:

                         

Domestic corporate commercial paper

    4,000             4,000  
                   

Total

  $ 4,000   $   $   $ 4,000  
                   

 

 
  December 31, 2011  
 
  Amortized Cost Value   Gross Unrealized Gains   Gross Unrealized Losses   Fair Value  

Cash and cash equivalents:

                         

Cash

  $ 5,003   $   $   $ 5,003  

Money market

    20,125             20,125  
                   

Total

  $ 25,128   $   $   $ 25,128  
                   

Marketable securities:

                         

Domestic corporate debt securities

    10,260         (6 )   10,254  

Domestic corporate commercial paper

    18,987     11         18,998  

U.S. government securities

    2,328             2,328  
                   

Total

  $ 31,575   $ 11   $ (6 ) $ 31,580  
                   

        There were no debt securities that had been in an unrealized loss position for more than 12 months as of December 31, 2012 or December 31, 2011. There were no debt securities in an unrealized loss position for less than 12 months at December 31, 2012 and there were 7 debt securities that had been in an unrealized loss position for less than 12 months at December 31, 2011. The aggregate unrealized loss on these securities as of December 31, 2011 was $6.0 thousand and the fair value was $8.0 million. The Company considered the decline in market value for these securities to be primarily attributable to current economic conditions. As it was not more likely than not that the Company would be required to sell these securities before the recovery of their amortized cost basis, which may be maturity, the Company did not consider these investments to be other-than-temporarily impaired as of December 31, 2011.